UCB SA(UCB.BR)— 技术面状态
数据截至2026-10-30 — 每个交易日晚间对全部覆盖范围重新计算。Closelook研究日记,不构成投资建议。
Trades +28.8% vs the 50-day and +16.5% vs the 200-day average, 2.4% below the 52-week high and +42.5% off the 52-week low; a death cross printed 59 sessions ago. Computed from daily closes.
均线状态
- 相对20日均线+23.2%
- 相对50日均线+28.8%
- 相对200日均线+16.5%
- 52周区间低于52周高点2.4% · 高于52周低点42.5%
- 连续走势连续3个交易日上涨
- 均线交叉死叉(59个交易日前)
- 50日均线交叉股价向上穿越50日均线(8个交易日前)
- 随机指标%K 97.9 · %D 93.5(金叉)
相关页面: UCB.BR图表与概览 · 质量与财务体检 · 信号看板
FAQ · from the current data · as of 2026-10-30
Quick answers
UCB.BR当前的Closelook信号是什么?
Recovery attempt under the 200-day — Trades +28.8% vs the 50-day and +16.5% vs the 200-day average, 2.4% below the 52-week high and +42.5% off the 52-week low; a death cross printed 59 sessions ago. Computed from daily closes.(截至2026-10-30;信号看板每个交易日晚间对全部覆盖范围重新计算。研究日记读数,不构成投资建议。)
UCB.BR目前是否位于50日和200日均线上方?
截至2026-10-30,UCB SA位于50日均线上方(+28.8%),200日均线上方(+16.5%);距20日均线+23.2%。
UCB.BR距52周高点有多远?
截至2026-10-30,低于52周高点2.4%,高于52周低点42.5%。
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- BION.SW BB Biotech AGindustry
- HALO Halozyme Therapeutics Incindustry
- ONC BeiGene, Ltd.industry
- ARGX.BR Argen-Xindustry
- ARGX argenx NV ADRindustry
- KRYS Krystal Biotech Incindustry
- KOD Kodiak Sciences Incindustry
- REPL Replimune Group Incindustry
- MRNA Moderna Incindustry
- ARQT Arcutis Biotherapeutics Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- ABSI Absci Corpindustry
- EXEL Exelixis Incindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- XNCR Xencor Incindustry
- ALK-B.CO ALK-Abelló A/Sindustry
- ADMA ADMA Biologics Incindustry
- VRDN Viridian Therapeutics Incindustry
- IRON Disc Medicine Inc.industry
- BHVN Biohaven Ltd.industry